GANYMED lead antibodies show excellent efficacy and safety in mouse tumor models Mainz, Germany – April 5, 2006 – GANYMED Pharmaceuticals AG announced today that several monoclonal lead antibodies directed against th

Source URL: www.ganymed-pharmaceuticals.com

• Medicine
• Clinical medicine
• Health care
• Immunology
• Pathology
• Immune system
• Monoclonal antibodies
• Immunohistochemistry
• Antibody
• Cancer
• IMAB362
• Racotumomab

Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer

Source URL: www.vaxira.com

Active immunotherapy in patients with progressive disease (PD) after first-line therapy: Racotumomab experience. R. E Gomez , S. Alfonso , E. Santiesteban , E. Neninger , M. Laura Ardigo , A. Maria Vazquez , T. Crombet ,

Source URL: www.recombio.com

• Eastern Cooperative Oncology Group
• End point of clinical trials
• Non-small-cell lung carcinoma
• Mapatumumab
• Medicine
• Lung cancer
• Oncology